Benitec Biopharma Future Growth
Future criteria checks 0/6
Benitec Biopharma is forecast to grow earnings and revenue by 40.8% and 70.3% per annum respectively while EPS is expected to grow by 51.1% per annum.
Key information
40.8%
Earnings growth rate
51.1%
EPS growth rate
| Biotechs earnings growth | 24.1% |
| Revenue growth rate | 70.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 13 Jun 2024 |
Recent future growth updates
No updates
Recent updates
Most Shareholders Will Probably Find That The Compensation For Benitec Biopharma Inc.'s (NASDAQ:BNTC) CEO Is Reasonable
Nov 30
Benitec Biopharma prices of $18M securities offering
Sep 13Benitec GAAP EPS of -$2.23, revenue of $0.07M
Sep 02We're A Little Worried About Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Rate
Jan 13We Think Benitec Biopharma (NASDAQ:BNTC) Needs To Drive Business Growth Carefully
Sep 30Will Benitec Biopharma (NASDAQ:BNTC) Spend Its Cash Wisely?
May 12Benitec Bio secures $13M capital via equity offering
Apr 28Can Benitec Biopharma (NASDAQ:BNTC) Afford To Invest In Growth?
Jan 27How Does Benitec Biopharma's (NASDAQ:BNTC) CEO Salary Compare to Peers?
Dec 02Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2027 | N/A | -36 | 70 | N/A | 1 |
| 6/30/2026 | N/A | -34 | 15 | N/A | 1 |
| 6/30/2025 | N/A | -28 | -29 | N/A | 2 |
| 6/30/2024 | N/A | -23 | -22 | N/A | 2 |
| 3/31/2024 | 0 | -22 | -20 | -20 | N/A |
| 12/31/2023 | 0 | -22 | -18 | -18 | N/A |
| 9/30/2023 | 0 | -20 | -19 | -19 | N/A |
| 6/30/2023 | 0 | -20 | -18 | -18 | N/A |
| 3/31/2023 | 0 | -20 | -19 | -19 | N/A |
| 12/31/2022 | 0 | -19 | -18 | -18 | N/A |
| 9/30/2022 | 0 | -18 | -16 | -16 | N/A |
| 6/30/2022 | 0 | -18 | -16 | -16 | N/A |
| 3/31/2022 | 0 | -17 | -16 | -16 | N/A |
| 12/31/2021 | 0 | -18 | -15 | -15 | N/A |
| 9/30/2021 | 0 | -16 | -15 | -15 | N/A |
| 6/30/2021 | 0 | -14 | -13 | -13 | N/A |
| 3/31/2021 | 0 | -13 | -11 | -11 | N/A |
| 12/31/2020 | 0 | -11 | -10 | -10 | N/A |
| 9/30/2020 | 0 | -10 | -10 | -9 | N/A |
| 6/30/2020 | 0 | -8 | -8 | -8 | N/A |
| 3/31/2020 | 1 | -7 | -6 | -6 | N/A |
| 12/31/2019 | 1 | -6 | N/A | N/A | N/A |
| 9/30/2019 | 7 | -2 | 2 | 2 | N/A |
| 6/30/2019 | 12 | 3 | 4 | 5 | N/A |
| 3/31/2019 | 12 | 2 | 4 | 4 | N/A |
| 12/31/2018 | 12 | 2 | N/A | N/A | N/A |
| 9/30/2018 | 8 | -3 | -3 | -3 | N/A |
| 6/30/2018 | 3 | -9 | -7 | -7 | N/A |
| 3/31/2018 | 4 | -9 | -7 | -7 | N/A |
| 12/31/2017 | 6 | -7 | N/A | -5 | N/A |
| 9/30/2017 | 5 | -7 | N/A | -5 | N/A |
| 6/30/2017 | 9 | -4 | N/A | -6 | N/A |
| 3/31/2017 | 7 | -7 | N/A | -6 | N/A |
| 12/31/2016 | 7 | -8 | N/A | -10 | N/A |
| 9/30/2016 | 7 | -12 | N/A | -13 | N/A |
| 6/30/2016 | 3 | -18 | N/A | -15 | N/A |
| 3/31/2016 | 3 | -18 | N/A | -17 | N/A |
| 12/31/2015 | 2 | -16 | N/A | -14 | N/A |
| 9/30/2015 | 2 | -12 | N/A | -10 | N/A |
| 6/30/2015 | 3 | -9 | N/A | -7 | N/A |
| 3/31/2015 | 3 | -6 | N/A | -5 | N/A |
| 12/31/2014 | 1 | -7 | N/A | -7 | N/A |
| 9/30/2014 | 1 | -7 | N/A | -8 | N/A |
| 6/30/2014 | 1 | -7 | N/A | -9 | N/A |
| 3/31/2014 | 1 | -5 | N/A | -8 | N/A |
| 12/31/2013 | 1 | -3 | N/A | -6 | N/A |
| 9/30/2013 | 1 | -3 | N/A | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BNTC is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BNTC is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BNTC is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BNTC is forecast to have no revenue next year.
High Growth Revenue: BNTC is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BNTC's Return on Equity is forecast to be high in 3 years time